Johns Hopkins CCGHE

@HopkinsCCGHE

Clinical training, education, tech, & leadership dev for researchers and providers to improve health outcomes in resource limited countries

Baltimore, Maryland
Vrijeme pridruživanja: rujan 2010.

Tweetovi

Blokirali ste korisnika/cu @HopkinsCCGHE

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @HopkinsCCGHE

  1. 13. sij

    Congratulations, Dr. Kathleen Page: Newly appointed Medical Director of The Access Partnership!

    Poništi
  2. 13. sij

    CCGHE joins ! Dir Bob Bollinger: " & big have potential to transform in many ways. Patients & communities that suffer the greatest burden of disease should benefit from disruptive technology"

    Poništi
  3. proslijedio/la je Tweet

    Long-acting/extended-release drugs for () should be developed to combat at same time for max effectiveness against two worldwide scourges, say docs in viewpoint.

    Poništi
  4. proslijedio/la je Tweet
    25. pro 2019.

    FujiLam increases sensitivity over AlereLam. AlereLam guidance updated by this year;usage shown to reduce mortality. Great work by team @SyddanskUniv

    Poništi
  5. proslijedio/la je Tweet

    “Access to long-acting drug formulations with dual activity against would be transformative …” say MDs in viewpoint.

    Poništi
  6. proslijedio/la je Tweet

    Researchers are close to discovering a new vaccines for 💉🌡🧬 The would train the immune system to make the antibodies in months instead of the natural timetable of years after human exposure to the virus.👨‍⚕️👩‍⚕️

    Poništi
  7. proslijedio/la je Tweet

    The virus attacks & inflames the liver, but our John G. Bartlett Specialty Practice improves the outlook for patients. See how.

    Poništi
  8. 10. pro 2019.

    Zero-ing in on eliminating catastrophic costs for tuberculosis: can active case finding help? -

    Poništi
  9. 5. pro 2019.

    We're looking for a Budget Analyst to join our team! JHU is among the world's leading research institutions and offers fantastic benefits, including tuition benefits for employees and dependents. Learn more about the position and apply here:

    Poništi
  10. 22. stu 2019.

    If you couldn't go to Hyderabad for this year's on Lung Health, you can still check out poster and slide presentations of CCGHE research --->

    Poništi
  11. 20. stu 2019.

    WHO updates policy for the lateral flow urine LAM assay for the diagnosis of active tuberculosis in people living with HIV:

    Poništi
  12. 20. stu 2019.

    Kudos to our colleagues at BJGMC and Sassoon for their focus on .

    Poništi
  13. 22. lis 2019.

    is top killer of HIV+ patients, & rapid improves survival. & team: LF-LAM point-of-care urine test may be rapid, simple way to detect TB and saves lives, esp when sputum is not available. More:

    Poništi
  14. 21. lis 2019.

    CCGHE researchers and faculty will be in Hyderbad for --check out our agenda!

    Poništi
  15. 11. lis 2019.

    New & super cool! JHU team & colleagues developed & tested a suite of apps for linking drug-resistant patients to care. Results of small study: 38% more patients in care 13-18 days quicker😎

    Poništi
  16. proslijedio/la je Tweet
    3. lis 2019.

    The IMPAACT Network is delighted to announce the publication of primary results from the IMPAACT P1078/TB APPRISE study in the 3 October 2019 issue of

    Poništi
  17. 30. ruj 2019.

    If you missed our TB Case Discussion last week, it is now available on-demand. The case was presented by Dr. Caitlin Reed from the Division of Infectious Diseases, and was hosted by Dr. Maunank Shah.

    Poništi
  18. 26. ruj 2019.

    If you missed yesterday's Global Grand Rounds in Infectious Diseases webcast, It is now available on demand. BYRAMJEE JEEJEEBHOY GOVERNMENT MEDICAL COLLEGE (BJGMC) presented.

    Poništi
  19. 25. ruj 2019.

    Tune in today at 1pm [EDT] for our TB Clinical Case Discussion webcast. The presentation will be "Issues in the Clinical Management of Active TB".

    Poništi
  20. 24. ruj 2019.

    Dr. Richard Chaisson and colleagues found a regimen that prevents tuberculosis with fewer side effects and is taken for only one month instead of 3. It's been slow to be adopted, placing more lives at risk.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·